We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 869

Advice of counsel defense in US v. Lauren Stevens: dismissal of indictment is not necessarily good news for companies
  • Hogan Lovells
  • USA
  • March 25 2011

The indictment last November of former GlaxoSmithKline (GSK) in-house counsel, Lauren Stevens, for purportedly obstructing a U.S. Food and Drug Administration (FDA) investigation into whether GSK marketed Wellbutrin, an anti-depressant drug, off-label, falsifying and concealing documents, and making false statements sent shockwaves through the legal community


D.C. Circuit decision in Friedman v. Sebelius overturns exclusions of three Purdue pharma executives
  • Sidley Austin LLP
  • USA
  • August 6 2012

In the pharmaceutical industry, government investigations initiated by whistleblower qui tam complaints canand often doresult in both civil and criminal charges against the company


State AGs in the news
  • Dickstein Shapiro LLP
  • USA
  • June 26 2014

Don Quick (D) and Cynthia Coffman (R) received their respective party's nomination after both ran unopposed in the primary. Incumbent AG John Suthers


Major cases only, please
  • Bracewell & Giuliani LLP
  • USA
  • July 7 2014

At the American Health Lawyers Association meeting last week, Department of Justice officials signaled that the Department may shift to a model of


Recent prison sentences demonstrate government intent to increase criminal prosecutions of liable corporate officials
  • Arnall Golden Gregory LLP
  • USA
  • December 5 2011

In late November, two former senior executives of Synthes Inc. were sentenced to nine months in prison and a third sentenced to five months in prison for their management roles in a company that marketed a medical device for an unauthorized use and conducted unauthorized clinical trials


How to respond to a search warrant - ten practical steps
  • Ober Kaler
  • USA
  • December 31 2013

Presented by Gina L. Simms and James P. Holloway of OberKaler's Government Investigations and White Collar Defense Group, this podcast provides


Responding to a government subpoena or other document demand - six helpful hints
  • Ober Kaler
  • USA
  • December 31 2013

Presented by Gina L. Simms and James P. Holloway of OberKaler's Government Investigations and White Collar Defense Group, this podcast provides


“The elephant in the room”: indictment of former GlaxoSmithKline in-house attorney dismissed due to prosecutors’ misstatement of advice of counsel defense to grand jurors
  • Jenner & Block
  • USA
  • March 24 2011

A federal district court has dismissed the indictment of a former in-house counsel at pharmaceutical company GlaxoSmithKline ("GSK"), Lauren Stevens, who was charged in November 2010 with obstruction of a proceeding, false statements, and falsifying or concealing documents, for her role in responding to a document request from the Food and Drug Administration ("FDA"


Former GSK in-house counsel Lauren Stevens acquitted
  • Kelley Drye & Warren LLP
  • USA
  • May 10 2011

Earlier today, Honorable Roger W. Titus, who is the judge presiding over the Lauren Stevens trial, granted the defendant's motion for a judgment of acquittal, bringing the case to an end


Ten steps global life sciences companies should take in 2011
  • Sidley Austin LLP
  • USA
  • February 16 2011

Focus on potential kickback, Foreign Corrupt Practices Act, and Good Clinical Practice liability, especially in developing countries